Attention deficit disorder in adults

Annals of Clinical Psychiatry

Volumn 14, Issue 2, 2002, Pages 105-111

  Pary, Raymond ^a,b   Lewis, Susan ^a   Matuschka, Paul R ^a   Rudzinskiy, Peter ^a   Safi, Mohammad ^b   Lippmann, Steven ^b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Adult; Attention deficit; Attention deficit disorder; Attention deficit hyperactivity disorder; Hyperactivity; Inattention

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; DESIPRAMINE; DEXAMPHETAMINE; GUANFACINE; IMIPRAMINE; METHYLPHENIDATE; MODAFINIL; PEMOLINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ABDOMINAL DISCOMFORT; ADULT; ANOREXIA; ATTENTION DEFICIT DISORDER; CHILD REARING; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; HEADACHE; HUMAN; HUMAN RELATION; IMPULSIVENESS; INSOMNIA; INVOLUNTARY MOVEMENT; IRRITABILITY; ONSET AGE; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOTHERAPY; REVIEW; SKILL; TOXIC HEPATITIS;

ADULT; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; FEEDBACK, PSYCHOLOGICAL; HUMANS; INTERPERSONAL RELATIONS; PREVALENCE; PSYCHOTHERAPY;

EID: 0036592818     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016807021779     Document Type: Review

References (49)

1. Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children
2. Hyperactive boys almost grown up, I: Psychiatric status
3. Hyperactive boys almost grown up, V: Replication of psychiatric status
4. Attention deficit hyperactivity disorder in adults
5. Age-dependent decline of attention deficit hyperactivity disorder
6. Attention deficit disorder in adults
7. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: Which is more valid
8. Executive function and attention deficit hyperactivity disorder: Stimulant medication and better executive function performance in children
9. Dopamine in schizophrenia: A review and reconceptualization
10. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder
11. Quantitative brain magnetic resonance imaging in attention deficit hyperactivity disorder
12. The neurobiology of attention-deficit/hyperactivity disorder
13. Assessing attention deficit hyperactivity disorder via quantitative electroencephalography: An initial validation study
14. Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene
15. Association of attention-deficit disorder and the dopamine transporter gene
16. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD
17. Attention-deficit/hyperactivity disorder: A life-span perspective
18. Adults with attention-deficit/hyperactivity disorder: A controversial diagnosis
19. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults
20. The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit disorder
21. ADHD in adults
22. Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults
23. Patterns of psychiatric comorbidity, cognition and psychosocial functioning in adults with attention deficit hyperactivity disorder
24. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers
25. Bipolar disorder: Diagnostic challenges and treatment considerations
26. Behavior of children receiving benzedrine
27. Pharmacology of attention-deficit hyperactivity disorder across the life cycle
28. Norepinephrine and epinephrine
29. A double-blind crossover comparison of methylphenidate and placebo in adults with childhood-onset attention deficit hyperactivity
30. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults
31. A comparison of morningonly and morning/late afternoon adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit hyperactivity disorder
32. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder
33. Once-a-day concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings
34. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults
35. An open trial of venlafaxine in the treatment of attention deficit/hyperactivity disorder in children and adolescents
36. Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: A pilot study
37. Pemoline-induced abnormal involuntary movements
38. Estimation of the association between desipramine and the risk for sudden death in 5 to 14-year-old children
39. Case study: Two additional sudden deaths with tricyclic antidepressants
40. Treatment of attention-deficit-hyperactivity disorder
41. Comparing guanfacine and dextroamphetamine for the treatment of adult attention deficit/hyperactivity disorder
42. Adults with attention hyperactivity disorder: Assessment and treatment considerations
43. Neurofeedback: Assessment and treatment for attention deficit/hyperactivity disorders: Introduction to quantitative EEG and neurofeedback